ClinicalTrials.Veeva

Menu

Effect of Technology on Cognitive Function in Elderly (cogntion)

N

Nourhan Hesham Ali

Status

Enrolling

Conditions

Cognitive Impairment

Treatments

Behavioral: cognitive therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT06378606
P.T.REC/012/004907

Details and patient eligibility

About

Cognitive technology therapies, including interactive video gaming, computer soft wares and mobile technology, have been used to implement cognitive training and rehabilitation programs. Potential advantages to using technology-based interventions include enhanced accessibility and cost-effectiveness, providing a user experience to be good communicator, immersive and comprehensive.

Full description

Aging over 60 years is associated with some progressive decline in cognitive domains, such as processing speed and executive function. A significant decline in cognitive function, particularly memory, which is an early symptom of dementia, can lead to mild cognitive impairment (MCI). Currently it is estimated that 50 million are living with dementia worldwide and nearly 10 million new cases occur every year, representing a serious public health problem. As such, the WHO has suggested that preventing cognitive decline and dementia is a global mental health priority. In addition to impacting the patient, dementia also has a significant impact on the family and society in general. Age is the biggest risk factor for the development of dementia, and aging is associated with a decline of cognitive function. Non-pharmacological interventions such as physical exercise and cognitive interventions may offer an alternative to pharmacological intervention in delaying dementia-related functional decline. Over the last decade, the accessibility and use of computers, smartphones and mobile internet has quickly expanded .

Cognitive technology therapies, including interactive video gaming, computer soft wares and mobile technology, have been used to implement cognitive training and rehabilitation programs. Potential advantages to using technology-based interventions include enhanced accessibility and cost-effectiveness, providing a user experience to be good communicator, immersive and comprehensive.

Enrollment

60 estimated patients

Sex

All

Ages

65 to 85 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

1- Age ≥ 65 years. 2- Literate with ≥ 15 years of education. 3- Older adults with mild dementia. 4- Montreal cognitive assessment score 18-26 .( Pinto et al .,2019). 5- Android smartphone user. 6- Well ability to write and read. Exclusion criteria

  1. Major Cardiovascular events , such as Stroke or Myocardial infraction in past three months.
  2. Alzheimer's disease.
  3. Sever cognitive dementia.
  4. Sever hearing difficulty or visual disturbance.
  5. Brain injury.
  6. Limitation in communications.
  7. Chronic kidney diseases.
  8. Liver diseases.
  9. Low or high educated.
  10. Uncontrolled diabetic patients.
  11. Thyroid disturbance.
  12. Mental and psychological instability .

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

60 participants in 3 patient groups, including a placebo group

group A
Active Comparator group
Description:
(Therapy group) It will include subjects that will receive computer based cognitive therapy sessions training. omega 3 supplement .
Treatment:
Behavioral: cognitive therapy
Group B
Experimental group
Description:
(Smartphone group) It will include subjects that will receive home program training by using their smartphones cognitive applications . omega 3 supplement .
Treatment:
Behavioral: cognitive therapy
group c
Placebo Comparator group
Description:
It won't receive interventions. only omega 3 supplement
Treatment:
Behavioral: cognitive therapy

Trial contacts and locations

1

Loading...

Central trial contact

kareem adel mohamed; nourhan hisham ali

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems